USE OF SUPRATHEL® IN SURGICAL, NON-SURGICAL AND ENZIMATICALLY DEBRIDED BURNS Objective We evaluated the use of Suprathel®, a synthetic copolymer membrane from polylactids that provides a temporary wound coverage in burn patients. Methods Since 2013, 29 patients with mid-dermal or deep-dermal burns were treated with suprathel® and evaluated retrospectively. Suprathel ® was applied: - After enzymatically debridement with Nexobrid® - After hydro-debridement with Versajet® - On donor sites - On mid-dermal non surgical burns The outer dressings were changed every 2-3 days and the evolution closely evaluated. Results A total of 4 patients had to be secondarily debrided and covered with split thickness skin grafts in areas not healing after a certain period. 3 patients had Suprathel® removed because of secondary infection. Optimal scarring results were obtained on the other 22 patients. Supathel® was easily adapted to wound surfaces. It was a well tolerated temporary coverage which reduced pain and lead to complete stable reepithelization of burns without higher incidence of hypertrophic cicatrization. Dressing changes considerably reduced the average time, as well as the need of additional anesthetic medication. Conclusions Supathel® allows a quick and stable reepithelization with a successful coverage result. It has proven to be a safe and effective option, reducing pain and use of opioids, protecting from bacterial and virical infection and allowing, due to its transparency, a good visualization of the wound through the entire healing process.
No datasets are available for this submission.
No license information is available for this submission.